login
  Password reminder
Spinal News
Contact the editor Visit Spinal News Twitter feed Visit Spinal News Facebook page
 

Jeffrey Goldstein


Thursday, 13 Oct 2011 10:57

Listed in Who’s Who in Medicine and Healthcare, Jeffrey Goldstein, clinical professor of orthopaedic surgery, New York University Hospital for Joint Diseases, New York, USA, has had an impressive career—his extensive achievements range from developing a unique surface morphology to helping a man with a fractured spine walk again in addition to being a first responder during 9/11. In addition to the innovations he has helped to develop, he still gets profound satisfaction from improving patients’ quality of life. He talks to Spinal News International about the people who have inspired him and his passion for spinal surgery.

 


When did you decide that you wanted a career in medicine and why specifically in orthopaedic surgery?

 

Many people in medicine are strongly influenced by their parents or close relatives when they are young. My parents are both retired teachers and they impressed upon me the necessity to excel in school. From high school, I attended Colgate University with a desire to progress on to medical school. At Colgate, I had a strong liberal arts curriculum and then attended medical school. Initially, I anticipated a career in reconstructive surgery but then gained exposure to orthopaedic surgery early in my internship.

 

Most of what we do in orthopaedics has a positive effect on quality of life. Our patients are generally healthy and appreciative of the opportunity to gain improved function. I had the opportunity to train with Henry Bohlman at University Hospitals in Cleveland. It was at that point that I had my first exposure to spine surgery. Dr Bohlman’s exemplary approach to patient care and leadership in orthopaedic science served as an example that I wanted to emulate, and I sought out further training in spinal surgery in Baltimore with Paul McAfee.

 

Which technique or technology has had a profound effect on your career?

 

Motion preservation and artificial disc replacement of the cervical and lumbosacral spine provided me with my first opportunity to participate in a level one research project. Not only we were able to demonstrate the beneficial effects of artificial discs for the treatment of cervical radiculopathy and degenerative disease of the lumbar spine, but we also were able to acquire level one data that demonstrated the benefits of anterior cervical discectomy and fusion for patients with neck and arm pain as a result of cervical radiculopathy. We also showed the benefits of spinal fusion for the treatment of recalcitrant low back pain.

 

Additionally, my participation in the Prodisc trials has given me the opportunity to share in the publication and presentation of some of the strongest evidence we have regarding the benefits of spinal surgery for our patients. During the past 10 years, I have shared ideas and learned from, as well as formed lifelong relationships with, many outstanding spinal surgeons, thought leaders, and academics. I have had the opportunity to teach and learn from others around the world and share our experiences of artificial disc replacement.

 

Who has inspired you in your career and what advice of theirs do you remember today?

 

I have had both the pleasure and privilege of working with several leaders in orthopaedic surgery. They have contributed to our field in different and unique ways. Dr Bohlman trained a group of leaders who I have had the opportunity to train with and learn from during my residency and fellowship. I did my fellowship training with Paul McAfee, who is also an innovator. Presently I work closely with Joseph Zuckerman, who is chairman of the Orthopaedic Department at New York University (NYU) Hospital for Joint Diseases and a past president of the American Academy of Orthopaedic Surgeons. I also work with Thomas Errico, who is the chief of the division of spine surgery at NYU Hospital for Joint Diseases and past president of the International Society for the Advancement of Spine Surgery (ISASS) and NASS. Both Dr Zuckerman and Dr Errico continue to serve as my mentors and have demonstrated the leadership qualities and confidence that allow them to achieve their goals while letting others participate and excel.

 

At the NYU Hospital for Joint Diseases, I partner with an esteemed group of spinal surgeons and each of them is accomplished in the spinal field. It is gratifying to collaborate with them as we learn from each other. Our group works well together and we routinely collaborate in the treatment of our patients. We have been successful in regularly attracting to our training programme talented and motivated spine fellows who have also gone out into the community and into academics to take care of patients with spinal disorders. There are many very smart and talented spinal surgeons who I have had the privilege of associating with and learning from.

 

As a keen inventor what have been your proudest moments?

 

We have developed a unique surface structure morphology, which allows us to promote and to control fusion and bony ingrowth into spine and orthopaedic implants and devices and thus, increase fusion success and implant stability. By understanding the wound healing process, we are able to control and manage it with our surface morphology to create a better fusion and tissue ingrowth environment.

 

How has orthopaedic surgery evolved since you began your career?

 

When I was a resident, one of my professors used to say “I do not need a study…. I know it works”. Well, he had a breadth of experience and was usually right and his patients had good results. However, the same does not hold true today inasmuch we now understand the necessity to use knowledge based on level one data to treat patients. Another one of my professors used to ask during our conferences “Is this what you know or what you believe?” What this meant to me is “Do we have the data to support what we believe to be true?” We have developed an array of treatment modalities for our patients. However, experience alone is no longer adequate support for deciding on treatment algorithms for our patients.

 

What are the three big questions in orthopaedic surgery that you would like to see the answers to?

 

  • How can we diagnose the source of low back pain?
  • Once we identify the source of a patient’s pain, when is surgery an appropriate treatment option and what type of surgery should be used?
  • In today’s economic and regulatory environment, how are we going to develop and prove new technologies and who is going to pay for them?

Jeffrey Goldstein
Jeffrey Goldstein

Can you describe your most memorable clinical case(s)?

 

As a chief resident, I took care of a young man who suffered a fracture to the cervical spine, an incomplete spinal cord injury and facet dislocation after diving into a lake. Through awake cervical traction, we were able to reduce the fracture and he walked out of the hospital. Just as memorable, but in sharp contrast with regard to outcome, would be my experience as a first responder at ground zero at the World Trade Center during 9/11. I responded with several of the orthopaedic residents from NYU Hospital for Joint Diseases and slept in the hospital for several days. We operated on a patient who suffered an incomplete thoracic cord injury in addition to multiple other injuries. Despite our best efforts, our patient died of multisystem organ failure several weeks later. More recently, while the results may be somewhat less dramatic, I take a great deal of personal satisfaction when patients return to the office following surgery pleased with their ability to resume their normal activities and enjoy their life and time with their families with improved function and diminished pain.

 

How do you see treatment of the spine developing in the future?

 

Spine treatment will need to focus on modalities that have been proven effective. I would hope that we continue to develop and prove the efficacy of both minimally invasive surgery and motion preservation. While the promise of minimally invasive surgery is quite compelling, we need to prove that the results are maximally effective. Progress in our understanding of biologics will also be key to future advances in spinal interventions and treatment. In addition to the clinical efficacy of these treatments, we will also be required to show society that they are economically viable.

 

What are your current areas of research?

 

My research continues to focus on motion preservation and artificial disc replacement of both the cervical and lumbar spine. As we collect longer term data on motion preservation, we will be able to prove or disprove our assumptions regarding the long-term benefits of motion preservation as it is related to adjacent segment disease. I continue to be involved in the research and development of spinal implants.

 

What is the most interesting paper you have come across recently?

 

It is difficult to choose one paper. We have recently published our experience with two level lumbar artificial lumbar disc replacements in the Journal of Bone and Joint Surgery (JBJS-A) and also presented our five-year experience with cervical artificial disc replacement.

 

Outside of medicine, what are your interests?

 

My wonderful wife Julie and I have two beautiful young children Lex (two and a half) and Carly (four and a half). I enjoy spending as much time as I can with my family—they keep me grounded and continually keep me focused on the “big picture”. My kids are some of the funniest people I know. My wife and I enjoy cooking and fine wine. I also like music (classic rock and country western in the operating room!), photography, and travel.

 

Fact File

 

Appointments

 

2010–present  Clinical professor of Orthopaedic Surgery; director of Spine Service-Education; associate director of Spine Fellowship, NYU Hospital for Joint Diseases

2003–present  Honorary police surgeon, New York Police Department

Education

1996  Fellow, reconstructive surgery of the spine, Maryland Spine Centre, Baltimore, Maryland, USA

1990  MD, SUNY Downstate Brooklyn, New York, USA (received the Summa Cum Laude, Distinction in Research)

1985  BA, Colgate University, Hamilton, New York, USA

 

Societies (selected)

 

2011  Society of Lateral Access Surgeons

2010  Chairman Membership Committee, International Society for Advancement of Spine Surgery

2010  American Orthopaedic Association

2008  Lumbar Spine Research Society

2004  Scoliosis Research Society

2001  International Society for Study of the Lumbar Spine

2000  Fellow, American Academy of Orthopaedic Surgeons

1998  Fellow, American College of Surgeons

1998  Cervical Spine Research Society

1997  North American Spine Society

1981  American Mensa Society

 

Awards and Honours (selected)

 

2010–present  Best Doctors in New York, New York Magazine

2010–present  America’s Most Compassionate Doctors

2010–present  America’s Top Doctors

2010–present  America’s Top Orthopedists

2008–present  Patient’s Choice Award

2002–present  Who’s Who in Medicine and Healthcare

2002–present  Who’s Who in Science and Engineering

 

 



Add New Comment

Most popular


Epidural glucocorticoid injections provide little or no benefit for spinal stenosis
Friday, 11 Jul 2014
A new study indicates that epidural injections of glucocorticoids and lidocaine provide little or no benefit compared with epidural injections of lidocaine alone for patients with lumbar spinal ... Epidural glucocorticoid injections provide little or no benefit for spinal stenosis

Trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment
Wednesday, 23 Jul 2014
The study followed patients at five leading academic centres and found a significant decrease (p <0.01) in pain scores after targeted radiofrequency ablation (t-RFA) with the Star (DFINE) tumour ... Trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment

CE mark for FLXfit 3D expandable interbody cage
Tuesday, 01 Jul 2014
Expanding Orthopedics has announced that the FLXfit, its novel expandable and articulated TLIF cage with lordotic correction, has received CE mark approval and is now cleared for commercialisation in ... CE mark for FLXfit 3D expandable interbody cage

Features


Managing back pain in children
Friday, 29 Aug 2014
Omar Gabbar reviews the prevalence and management of back pain in children and adolescents, including the importance of excluding serious pathologies. Managing back pain in children

The ASIA impairment scale for spinal injuries may show worsening despite neurological improvement
Thursday, 31 Jul 2014
Ibrahim Gündoğdu and colleagues report in Spinal Cord that the American Spinal Injury Association (ASIA) impairment scale is limited because it could show worsening despite a patient with a spinal ... The ASIA impairment scale for spinal injuries may show worsening despite neurological improvement

Profiles


Lori Karol
Wednesday, 13 Aug 2014
Lori Karol, Texas Scottish Rite Hospital, Dallas, USA, talks to Spinal News International about the ... Lori Karol

Luiz Pimenta
Thursday, 12 Jun 2014
Luiz Pimenta, immediate past president of the International Society for the Advancement of Spinal S... Luiz Pimenta

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions